文献速递免疫规划传染病防控与疫情报告

首次接种麻疹疫苗的年龄与接种后时间对麻疹疫苗效果的影响——一项系统综述

The effect of time since measles vaccination and age at first dose on measles vaccine effectiveness - A systematic review.
PubMed 文献 · Vaccine · 2019-11-12

麻疹流行地区数据显示,首剂含麻疹疫苗(MCV)接种年龄每增加1个月,单剂VE提高1.5%(95%CI 0.5, 2.5),未发现VE随时间减弱的证据;麻疹消除地区数据太少,无法明确VE是否减弱。

要点

  • 麻疹流行地区:首剂MCV接种年龄每增加1个月,单剂VE提高1.5%(95%CI 0.5, 2.5)
  • 麻疹流行地区未发现VE随时间减弱的证据
  • 麻疹消除地区仅3篇文献,VE是否减弱无法明确,需更多研究

核心结论

  • 麻疹消除地区数据匮乏,需开展更多研究及方法(如使用保护性实验室相关指标的替代研究)来回答VE是否减弱的问题。
  • 首剂MCV接种年龄是决定VE的最重要因素。
  • 需在麻疹消除地区开展更多VE研究,并制定此类研究信息收集与报告的标准。

研究设计与样本

  • 系统文献综述,纳入报告含麻疹疫苗(MCV)接种后时间与疫苗效果(VE)的研究。
  • 提取信息包括病例定义(临床症状和/或实验室诊断)、接种状态确认方法(病历或疫苗登记)以及冷链问题和缺乏首剂MCV接种年龄可能引入的偏倚。
  • 采用线性回归评估VE与首剂MCV接种年龄及接种后时间的关系。

主要发现

  • 麻疹消除地区:两项剂量VE估计随首剂MCV接种年龄增加而升高,随接种后时间延长而降低;但可用研究数量少,限制了结果解读。
  • 麻疹流行地区:首剂MCV接种年龄每增加1个月,单剂VE提高1.5%(95%CI 0.5, 2.5)。
  • 麻疹流行地区未发现VE随时间减弱的证据。

关键数值与推荐

  • 麻疹流行地区:首剂MCV接种年龄每增加1个月,单剂VE提高1.5%(95%CI 0.5, 2.5)。
  • 麻疹消除地区:两剂VE估计随首剂接种年龄增加而升高、随接种后时间延长而降低,但研究数量少限制解读。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 麻疹消除地区可用研究数量少(仅3篇全文文献),限制了结果解读。
  • 麻疹消除地区数据匮乏,需开展更多研究及方法(如使用保护性实验室相关指标的替代研究)来回答VE是否减弱的问题。
  • 需在麻疹消除地区开展更多VE研究,并制定此类研究信息收集与报告的标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In settings where measles has been eliminated, vaccine-derived immunity may in theory wane more rapidly due to a lack of immune boosting by circulating measles virus. We aimed to assess whether measles vaccine effectiveness (VE) waned over time, and if so, whether differentially in measles-eliminated and measles-endemic settings. METHODS: We performed a systematic literature review of studies that reported VE and time since vaccination with measles-containing vaccine (MCV). We extracted information on case definition (clinical symptoms and/or laboratory diagnosis), method of vaccination status ascertainment (medical record or vaccine registry), as well as any biases which may have arisen from cold chain issues and a lack of an age at first dose of MCV. We then used linear regression to evaluate VE as a function of age at first dose of MCV and time since MCV. RESULTS: After screening 14,782 citations, we identified three full-text articles from measles-eliminated settings and 33 articles from measles-endemic settings. In elimination settings, two-dose VE estimates increased as age at first dose of MCV increased and decreased as time since MCV increased; however, the small number of studies available limited interpretation. In measles-endemic settings, one-dose VE increased by 1.5% (95% CI 0.5, 2.5) for every month increase in age at first dose of MCV. We found no evidence of waning VE in endemic settings. CONCLUSIONS: The paucity of data from measles-eliminated settings indicates that additional studies and approaches (such as studies using proxies including laboratory correlates of protection) are needed to answer the question of whether VE in measles-eliminated settings wanes. Age at first dose of MCV was the most important factor in determining VE. More VE studies need to be conducted in elimination settings, and standards should be developed for information collected and reported in such studies.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hughes SL, Bolotin S, Khan S, et al. The effect of time since measles vaccination and age at first dose on measles vaccine effectiveness - A systematic review. Vaccine. 2019. PMID: 31732326. doi:10.1016/j.vaccine.2019.10.090

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。